Consumer health company Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe.
He will oversee the business’ UK, Ireland, Norway, Sweden, Denmark and Finland operations, managing brands such as Aveeno, Johnson’s Baby, Listerine and Neutrogena.
“Vorsteveld brings over three decades of experience in consumer goods and healthcare to the role,” said Carlton Lawson, Group President, Europe, Middle East, Africa and Latin America at Kenvue.
“[He] brings a proven track record of delivering industry-leading growth, building high-performing teams and deep industry knowledge that will be invaluable as we work to further boost Kenvue’s regional performance and growth,” Lawson added.
“I am confident that his experience advocating for the role our industry can and should play in promoting the value of self care will help us deliver on our clear purpose to put the power of everyday care into the hands of more consumers.”
Vorsteveld was VP and GM for Great Britain and Ireland (GBI) at consumer healthcare company Haleon before joining Kenvue.
He has also held several roles with GSK Consumer Healthcare including VP & Head of Commercial Excellence EMEA and VP and GM of France and French speaking Africa & Maghreb.
Vorsteveld was also GM at the Swiss multinational pharmaceutical corporation Novartis and started his career at Dutch dairy company Campina.
“Kenvue’s iconic brands speak for themselves, and I am excited by the truly holistic approach to self-care we can offer through the entire range of different categories we thrive in,” said Vorsteveld.
“I’m thrilled to join the Northern Europe team, and I look forward to getting out across the region to spend time with our customers and stakeholders across the industry as well as our dedicated team.”
Kenvue began as the standalone consumer health company of Johnson & Johnson, becoming a fully independent company in August 2023.